Testing effectiveness (Phase 2)Study completedNCT02960997
What this trial is testing
Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study
Who this might be right for
Epidermolysis Bullosa SimplexEpidermolysis Bullosa Simplex KobnerWeber-Cockayne Syndrome
Stanford University 8